Alzheimer's disease theranostics / Magisetty Obulesu.
Obulesu, Magisetty.| Call Number | 616.831 |
| Author | Obulesu, Magisetty. |
| Title | Alzheimer's disease theranostics / Magisetty Obulesu. |
| Publication | London : Elsevier, 2019. |
| Physical Description | 1 online resource |
| Contents | Front Cover; Alzheimer's Disease Theranostics; Alzheimer's Disease Theranostics; Copyright; Dedication; Biography; Acknowledgements; Contents; 1 -- Introduction: Alzheimer's Disease Pathology and Therapeutics; ABSTRACT; KEYWORDS; INTRODUCTION; BIOCHEMISTRY; THERANOSTICS; Antibodies; Natural Compounds; Resveratrol; Ginkgo Biloba; Drugs; Nanotechnology; CONCLUSION AND FUTURE PERSPECTIVES; REFERENCES; 2 -- Early Diagnosis of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; CURCUMIN; CREATIVE DRAWING TECHNIQUE; Imaging Techniques; Positron Emission Tomography Radiotracers; GENETICS BIOMARKERSBlood Biomarkers; Protein Biomarkers; MIRNA; GLUCOSE LEVELS; CONCLUSION; REFERENCES; 3 -- Antioxidants in Alzheimer's Therapy; ABSTRACT; KEYWORDS; INTRODUCTION; ANTIOXIDANTS; Plant Extracts; Withanolides; NEUROINFLAMMATION-TARGETED THERAPEUTICS; Antioxidant Enzymes; Limitations; MELATONIN; LIPOIC ACID; NANOTECHNOLOGY; CONCLUSION; REFERENCES; 4 -- Natural Products in the Treatment of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; FLAVONOIDS; Epigallocatechin-3-Gallate; RESVERATROL; SAIKOSAPONINS; CURCUMIN; CLICK CHEMISTRY; NANOTECHNOLOGY; CHITOSAN; CONCLUSION; REFERENCES 5 -- Blood-Brain Barrier-Targeted Nanotechnological AdvancesABSTRACT; KEYWORDS; INTRODUCTION; PHYSIOLOGY; PATHOLOGY; BCSFB; THERAPEUTICS; Matrix Metalloproteinases; Nanoparticles; Gold nanoparticles; Liposomes; Magnetic nanoparticles; CONCLUSIONS AND FUTURE PERSPECTIVES; REFERENCES; 6 -- Gene Therapy: The Cornerstone in the Development of Alzheimer's Disease Therapeutics; ABSTRACT; KEYWORDS; INTRODUCTION; PRESENILIN; STEM CELLS; MICRORNA/CDK5R1; HEAT SHOCK PROTEIN; BECLIN; APOLIPOPROTEIN E; DRUG MECHANISM/GENE MODIFICATION; NEUROINFLAMMATION AND CYTOKINES; CONCLUSION; REFERENCES 7 -- Viral Vector Therapeutics Against Alzheimer's DiseaseABSTRACT; KEYWORDS; INTRODUCTION; Viral Vector Therapeutics; Adeno-Associated Viral Vectors; mAbs; Tau; PROGRANULIN; NEPRILYSIN; GENE-BASED IMMUNOTHERAPEUTIC METHODS; CONCLUSION; REFERENCES; 8 -- Mitochondria-Targeted Nanoparticles: A Milestone or a Mirage in the Treatment of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; Nanoparticles; Flurbiprofen Nanoparticles; Nattokinase Nanoparticles; Intranasal Delivery; Triphenylphosphonium Functionalization; Cerium Oxide Nanoparticles; CONCLUSION; REFERENCES 9 -- Nanoparticles: The Double-Edged SwordsABSTRACT; KEYWORDS; INTRODUCTION; Nanotechnology; Polymeric Materials; Carbon Nanotubes; Hydrogels; Tissue Engineering Scaffolds; Delivery Systems for Growth Factors; Delivery Systems for Chelators; DEMERITS OF BIOMATERIALS; CONCLUSIONS AND FUTURE PERSPECTIVES; REFERENCES; 10 -- Alzheimer Therapeutics: Pros and Cons; ABSTRACT; KEYWORDS; INTRODUCTION; Neuroinflammation and Cytokines; Demerits; Antioxidants; Shortcomings; DRUG MECHANISM/GENE MODIFICATION; Neprilysin; Limitations; Nanotechnology; Gold Nanoparticles; Liposomes; Magnetic Nanoparticles |
| Subject | ALZHEIMER'S DISEASE. Alzheimer Disease Theranostic Nanomedicine Maladie d'Alzheimer. HEALTH & FITNESS Diseases General. MEDICAL Clinical Medicine. MEDICAL Diseases. MEDICAL Evidence-Based Medicine. MEDICAL Internal Medicine. Alzheimer's disease. Electronic books. Electronic books. |
| Multimedia |
Total Ratings:
0
05395cam a2200673 a 4500
001
vtls001596325
003
VRT
005
20220902124800.0
006
m o d
007
cr cnu---unuuu
008
220902s2019 enk ob 001 0 eng d
015
$a GBB925709 $2 bnb
019
$a 1083341395 $a 1083575702 $a 1235828891
020
$a 9780128167397 $q (electronic bk.)
020
$a 0128167394 $q (electronic bk.)
020
$z 9780128164129
020
$z 0128164123
035
$a (OCoLC)1083460118 $z (OCoLC)1083341395 $z (OCoLC)1083575702 $z (OCoLC)1235828891
035
$a (OCoLC)on1083460118
039
9
$y 202209021248 $z santha
040
$a YDX $b eng $e pn $c YDX $d N$T $d EBLCP $d OPELS $d OCLCF $d OCLCQ $d DKU $d OCLCO $d OCLCQ $d S2H $d OCLCO $d UX1 $d VT2 $d OCLCA $d OCLCQ $d OCLCO $d K6U
050
4
$a RC523
060
4
$a 2019 C-919
060
4
$a WT 155
072
7
$a HEA $x 039000 $2 bisacsh
072
7
$a MED $x 014000 $2 bisacsh
072
7
$a MED $x 022000 $2 bisacsh
072
7
$a MED $x 112000 $2 bisacsh
072
7
$a MED $x 045000 $2 bisacsh
082
0
4
$a 616.831 $2 23
100
1
$a Obulesu, Magisetty.
245
1
0
$a Alzheimer's disease theranostics / $c Magisetty Obulesu.
260
$a London : $b Elsevier, $c 2019.
300
$a 1 online resource
336
$a text $b txt $2 rdacontent
337
$a computer $b c $2 rdamedia
338
$a online resource $b cr $2 rdacarrier
504
$a Includes bibliographical references and index.
505
0
$a Front Cover; Alzheimer's Disease Theranostics; Alzheimer's Disease Theranostics; Copyright; Dedication; Biography; Acknowledgements; Contents; 1 -- Introduction: Alzheimer's Disease Pathology and Therapeutics; ABSTRACT; KEYWORDS; INTRODUCTION; BIOCHEMISTRY; THERANOSTICS; Antibodies; Natural Compounds; Resveratrol; Ginkgo Biloba; Drugs; Nanotechnology; CONCLUSION AND FUTURE PERSPECTIVES; REFERENCES; 2 -- Early Diagnosis of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; CURCUMIN; CREATIVE DRAWING TECHNIQUE; Imaging Techniques; Positron Emission Tomography Radiotracers; GENETICS
505
8
$a BIOMARKERSBlood Biomarkers; Protein Biomarkers; MIRNA; GLUCOSE LEVELS; CONCLUSION; REFERENCES; 3 -- Antioxidants in Alzheimer's Therapy; ABSTRACT; KEYWORDS; INTRODUCTION; ANTIOXIDANTS; Plant Extracts; Withanolides; NEUROINFLAMMATION-TARGETED THERAPEUTICS; Antioxidant Enzymes; Limitations; MELATONIN; LIPOIC ACID; NANOTECHNOLOGY; CONCLUSION; REFERENCES; 4 -- Natural Products in the Treatment of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; FLAVONOIDS; Epigallocatechin-3-Gallate; RESVERATROL; SAIKOSAPONINS; CURCUMIN; CLICK CHEMISTRY; NANOTECHNOLOGY; CHITOSAN; CONCLUSION; REFERENCES
505
8
$a 5 -- Blood-Brain Barrier-Targeted Nanotechnological AdvancesABSTRACT; KEYWORDS; INTRODUCTION; PHYSIOLOGY; PATHOLOGY; BCSFB; THERAPEUTICS; Matrix Metalloproteinases; Nanoparticles; Gold nanoparticles; Liposomes; Magnetic nanoparticles; CONCLUSIONS AND FUTURE PERSPECTIVES; REFERENCES; 6 -- Gene Therapy: The Cornerstone in the Development of Alzheimer's Disease Therapeutics; ABSTRACT; KEYWORDS; INTRODUCTION; PRESENILIN; STEM CELLS; MICRORNA/CDK5R1; HEAT SHOCK PROTEIN; BECLIN; APOLIPOPROTEIN E; DRUG MECHANISM/GENE MODIFICATION; NEUROINFLAMMATION AND CYTOKINES; CONCLUSION; REFERENCES
505
8
$a 7 -- Viral Vector Therapeutics Against Alzheimer's DiseaseABSTRACT; KEYWORDS; INTRODUCTION; Viral Vector Therapeutics; Adeno-Associated Viral Vectors; mAbs; Tau; PROGRANULIN; NEPRILYSIN; GENE-BASED IMMUNOTHERAPEUTIC METHODS; CONCLUSION; REFERENCES; 8 -- Mitochondria-Targeted Nanoparticles: A Milestone or a Mirage in the Treatment of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; Nanoparticles; Flurbiprofen Nanoparticles; Nattokinase Nanoparticles; Intranasal Delivery; Triphenylphosphonium Functionalization; Cerium Oxide Nanoparticles; CONCLUSION; REFERENCES
505
8
$a 9 -- Nanoparticles: The Double-Edged SwordsABSTRACT; KEYWORDS; INTRODUCTION; Nanotechnology; Polymeric Materials; Carbon Nanotubes; Hydrogels; Tissue Engineering Scaffolds; Delivery Systems for Growth Factors; Delivery Systems for Chelators; DEMERITS OF BIOMATERIALS; CONCLUSIONS AND FUTURE PERSPECTIVES; REFERENCES; 10 -- Alzheimer Therapeutics: Pros and Cons; ABSTRACT; KEYWORDS; INTRODUCTION; Neuroinflammation and Cytokines; Demerits; Antioxidants; Shortcomings; DRUG MECHANISM/GENE MODIFICATION; Neprilysin; Limitations; Nanotechnology; Gold Nanoparticles; Liposomes; Magnetic Nanoparticles
588
0
$a Online resource; title from PDF title page (EBSCO, viewed January 31, 2019)
650
0
$a ALZHEIMER'S DISEASE.
650
2
$a Alzheimer Disease $0 (DNLM)D000544
650
2
$a Theranostic Nanomedicine $0 (DNLM)D000068936
650
6
$a Maladie d'Alzheimer. $0 (CaQQLa)201-0114128
650
7
$a HEALTH & FITNESS $x Diseases $x General. $2 bisacsh
650
7
$a MEDICAL $x Clinical Medicine. $2 bisacsh
650
7
$a MEDICAL $x Diseases. $2 bisacsh
650
7
$a MEDICAL $x Evidence-Based Medicine. $2 bisacsh
650
7
$a MEDICAL $x Internal Medicine. $2 bisacsh
650
7
$a Alzheimer's disease. $2 fast $0 (OCoLC)fst00806532
655
0
$a Electronic books.
655
4
$a Electronic books.
776
0
8
$i Print version: $a Obulesu, Magisetty. $t Alzheimer's disease theranostics. $d London : Elsevier, 2019 $z 0128164123 $z 9780128164129 $w (OCoLC)1044835474
856
4
0
$3 ScienceDirect $u https://www.sciencedirect.com/science/book/9780128164129
999
$a VIRTUA
No Reviews to Display
| Contents | Front Cover; Alzheimer's Disease Theranostics; Alzheimer's Disease Theranostics; Copyright; Dedication; Biography; Acknowledgements; Contents; 1 -- Introduction: Alzheimer's Disease Pathology and Therapeutics; ABSTRACT; KEYWORDS; INTRODUCTION; BIOCHEMISTRY; THERANOSTICS; Antibodies; Natural Compounds; Resveratrol; Ginkgo Biloba; Drugs; Nanotechnology; CONCLUSION AND FUTURE PERSPECTIVES; REFERENCES; 2 -- Early Diagnosis of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; CURCUMIN; CREATIVE DRAWING TECHNIQUE; Imaging Techniques; Positron Emission Tomography Radiotracers; GENETICS BIOMARKERSBlood Biomarkers; Protein Biomarkers; MIRNA; GLUCOSE LEVELS; CONCLUSION; REFERENCES; 3 -- Antioxidants in Alzheimer's Therapy; ABSTRACT; KEYWORDS; INTRODUCTION; ANTIOXIDANTS; Plant Extracts; Withanolides; NEUROINFLAMMATION-TARGETED THERAPEUTICS; Antioxidant Enzymes; Limitations; MELATONIN; LIPOIC ACID; NANOTECHNOLOGY; CONCLUSION; REFERENCES; 4 -- Natural Products in the Treatment of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; FLAVONOIDS; Epigallocatechin-3-Gallate; RESVERATROL; SAIKOSAPONINS; CURCUMIN; CLICK CHEMISTRY; NANOTECHNOLOGY; CHITOSAN; CONCLUSION; REFERENCES 5 -- Blood-Brain Barrier-Targeted Nanotechnological AdvancesABSTRACT; KEYWORDS; INTRODUCTION; PHYSIOLOGY; PATHOLOGY; BCSFB; THERAPEUTICS; Matrix Metalloproteinases; Nanoparticles; Gold nanoparticles; Liposomes; Magnetic nanoparticles; CONCLUSIONS AND FUTURE PERSPECTIVES; REFERENCES; 6 -- Gene Therapy: The Cornerstone in the Development of Alzheimer's Disease Therapeutics; ABSTRACT; KEYWORDS; INTRODUCTION; PRESENILIN; STEM CELLS; MICRORNA/CDK5R1; HEAT SHOCK PROTEIN; BECLIN; APOLIPOPROTEIN E; DRUG MECHANISM/GENE MODIFICATION; NEUROINFLAMMATION AND CYTOKINES; CONCLUSION; REFERENCES 7 -- Viral Vector Therapeutics Against Alzheimer's DiseaseABSTRACT; KEYWORDS; INTRODUCTION; Viral Vector Therapeutics; Adeno-Associated Viral Vectors; mAbs; Tau; PROGRANULIN; NEPRILYSIN; GENE-BASED IMMUNOTHERAPEUTIC METHODS; CONCLUSION; REFERENCES; 8 -- Mitochondria-Targeted Nanoparticles: A Milestone or a Mirage in the Treatment of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; Nanoparticles; Flurbiprofen Nanoparticles; Nattokinase Nanoparticles; Intranasal Delivery; Triphenylphosphonium Functionalization; Cerium Oxide Nanoparticles; CONCLUSION; REFERENCES 9 -- Nanoparticles: The Double-Edged SwordsABSTRACT; KEYWORDS; INTRODUCTION; Nanotechnology; Polymeric Materials; Carbon Nanotubes; Hydrogels; Tissue Engineering Scaffolds; Delivery Systems for Growth Factors; Delivery Systems for Chelators; DEMERITS OF BIOMATERIALS; CONCLUSIONS AND FUTURE PERSPECTIVES; REFERENCES; 10 -- Alzheimer Therapeutics: Pros and Cons; ABSTRACT; KEYWORDS; INTRODUCTION; Neuroinflammation and Cytokines; Demerits; Antioxidants; Shortcomings; DRUG MECHANISM/GENE MODIFICATION; Neprilysin; Limitations; Nanotechnology; Gold Nanoparticles; Liposomes; Magnetic Nanoparticles |
| Subject | ALZHEIMER'S DISEASE. Alzheimer Disease Theranostic Nanomedicine Maladie d'Alzheimer. HEALTH & FITNESS Diseases General. MEDICAL Clinical Medicine. MEDICAL Diseases. MEDICAL Evidence-Based Medicine. MEDICAL Internal Medicine. Alzheimer's disease. Electronic books. Electronic books. |
| Multimedia |